Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 314620, 11 pages
http://dx.doi.org/10.1155/2015/314620
Review Article

Th17 Cell Plasticity and Functions in Cancer Immunity

Department of Pathology and Immunology, University of Geneva Medical School, 1211 Geneva, Switzerland

Received 3 April 2015; Accepted 1 June 2015

Academic Editor: Nona Janikashvili

Copyright © 2015 Leslie Guéry and Stéphanie Hugues. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. E. Harrington, R. D. Hatton, P. R. Mangan et al., “Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages,” Nature Immunology, vol. 6, no. 11, pp. 1123–1132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Park, Z. Li, X. O. Yang et al., “A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17,” Nature Immunology, vol. 6, no. 11, pp. 1133–1141, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Korn, E. Bettelli, M. Oukka, and V. K. Kuchroo, “IL-17 and Th17 cells,” Annual Review of Immunology, vol. 27, pp. 485–517, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. C. L. Langrish, Y. Chen, W. M. Blumenschein et al., “IL-23 drives a pathogenic T cell population that induces autoimmune inflammation,” The Journal of Experimental Medicine, vol. 201, no. 2, pp. 233–240, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. I. I. Ivanov, B. S. McKenzie, L. Zhou et al., “The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells,” Cell, vol. 126, no. 6, pp. 1121–1133, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Annunziato, L. Cosmi, V. Santarlasci et al., “Phenotypic and functional features of human Th17 cells,” The Journal of Experimental Medicine, vol. 204, no. 8, pp. 1849–1861, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. X. O. Yang, B. P. Pappu, R. Nurieva et al., “T helper 17 lineage differentiation is programmed by orphan nuclear receptors RORα and RORγ,” Immunity, vol. 28, no. 1, pp. 29–39, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Durant, W. T. Watford, H. L. Ramos et al., “Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis,” Immunity, vol. 32, no. 5, pp. 605–615, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. B. U. Schraml, K. Hildner, W. Ise et al., “The AP-1 transcription factor Batf controls TH17 differentiation,” Nature, vol. 460, no. 7253, pp. 405–409, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Huber, A. Brüstle, K. Reinhard et al., “IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 52, pp. 20846–20851, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. F. J. Quintana, A. S. Basso, A. H. Iglesias et al., “Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor,” Nature, vol. 453, no. 7191, pp. 65–71, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Veldhoen, K. Hirota, A. M. Westendorf et al., “The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins,” Nature, vol. 453, no. 7191, pp. 106–109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. S. A. Khader, S. L. Gaffen, and J. K. Kolls, “Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa,” Mucosal Immunology, vol. 2, no. 5, pp. 403–411, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Fossiez, O. Djossou, P. Chomarat et al., “T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines,” The Journal of Experimental Medicine, vol. 183, no. 6, pp. 2593–2603, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Ye, F. H. Rodriguez, S. Kanaly et al., “Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense,” The Journal of Experimental Medicine, vol. 194, no. 4, pp. 519–527, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Pelletier, L. Maggi, A. Micheletti et al., “Evidence for a cross-talk between human neutrophils and Th17 cells,” Blood, vol. 115, no. 2, pp. 335–343, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. S. C. Liang, X.-Y. Tan, D. P. Luxenberg et al., “Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides,” The Journal of Experimental Medicine, vol. 203, no. 10, pp. 2271–2279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Mitsdoerffer, Y. Lee, A. Jäger et al., “Proinflammatory T helper type 17 cells are effective B-cell helpers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 32, pp. 14292–14297, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Martin-Orozco, P. Muranski, Y. Chung et al., “T helper 17 cells promote cytotoxic T cell activation in tumor immunity,” Immunity, vol. 31, no. 5, pp. 787–798, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. M. A. Munegowda, Y. Deng, S. J. Mulligan, and J. Xiang, “Th17 and Th17-stimulated CD8+ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity,” Cancer Immunology, Immunotherapy, vol. 60, no. 10, pp. 1473–1484, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Nistala, S. Adams, H. Cambrook et al., “Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 33, pp. 14751–14756, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Kebir, I. Ifergan, J. I. Alvarez et al., “Preferential recruitment of interferon-γ-expressing TH17 cells in multiple sclerosis,” Annals of Neurology, vol. 66, no. 3, pp. 390–402, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. K. Lee, H. Turner, C. L. Maynard et al., “Late developmental plasticity in the T helper 17 lineage,” Immunity, vol. 30, no. 1, pp. 92–107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Rizzo, V. De Mare, C. Rocchi et al., “Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells,” Carcinogenesis, vol. 35, no. 7, pp. 1536–1546, 2014. View at Publisher · View at Google Scholar
  25. L. Cosmi, R. Cimaz, L. Maggi et al., “Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis,” Arthritis and Rheumatism, vol. 63, no. 8, pp. 2504–2515, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Bending, H. de la Peña, M. Veldhoen et al., “Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice,” The Journal of Clinical Investigation, vol. 119, no. 3, pp. 565–572, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Hirota, J. H. Duarte, M. Veldhoen et al., “Fate mapping of IL-17-producing T cells in inflammatory responses,” Nature Immunology, vol. 12, no. 3, pp. 255–263, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Wang, J. Godec, K. Ben-Aissa et al., “The transcription factors T-bet and runx are required for the ontogeny of pathogenic interferon-γ-producing T helper 17 cells,” Immunity, vol. 40, no. 3, pp. 355–366, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. C. E. Zielinski, F. Mele, D. Aschenbrenner et al., “Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β,” Nature, vol. 484, no. 7395, pp. 514–518, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Wei, L. Wei, J. Zhu et al., “Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells,” Immunity, vol. 30, no. 1, pp. 155–167, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Liu, A. T. Cao, T. Feng et al., “TGF-β converts Th1 cells into Th17 cells through stimulation of Runx1 expression,” European Journal of Immunology, vol. 45, no. 4, pp. 1010–1018, 2015. View at Publisher · View at Google Scholar
  32. D. Mucida, Y. Park, G. Kim et al., “Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid,” Science, vol. 317, no. 5835, pp. 256–260, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. E. V. Dang, J. Barbi, H.-Y. Yang et al., “Control of TH17/Treg balance by hypoxia-inducible factor 1,” Cell, vol. 146, no. 5, pp. 772–784, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Z. Shi, R. Wang, G. Huang et al., “HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells,” The Journal of Experimental Medicine, vol. 208, no. 7, pp. 1367–1376, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Berod, C. Friedrich, A. Nandan et al., “De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells,” Nature Medicine, vol. 20, no. 11, pp. 1327–1333, 2014. View at Publisher · View at Google Scholar
  36. M. S. Sundrud and C. Trivigno, “Identity crisis of Th17 cells: many forms, many functions, many questions,” Seminars in Immunology, vol. 25, no. 4, pp. 263–272, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Poutahidis, M. Kleinewietfeld, C. Smillie et al., “Microbial reprogramming inhibits Western diet-associated obesity,” PLoS ONE, vol. 8, no. 7, Article ID e68596, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. H. J. P. M. Koenen, R. L. Smeets, P. M. Vink, E. van Rijssen, A. M. H. Boots, and I. Joosten, “Human CD25highFoxp3pos regulatory T cells differentiate into IL-17 producing cells,” Blood, vol. 112, no. 6, pp. 2340–2352, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Valmori, C. Raffin, I. Raimbaud, and M. Ayyoub, “Human RORγt+ TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 45, pp. 19402–19407, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. X. O. Yang, R. Nurieva, G. J. Martinez et al., “Molecular antagonism and plasticity of regulatory and inflammatory T cell programs,” Immunity, vol. 29, no. 1, pp. 44–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. K. S. Voo, Y.-H. Wang, F. R. Santori et al., “Identification of IL-17-producing FOXP3+ regulatory T cells in humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 12, pp. 4793–4798, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. X. Zhou, S. L. Bailey-Bucktrout, L. T. Jeker et al., “Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo,” Nature Immunology, vol. 10, no. 9, pp. 1000–1007, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. H. J. Bovenschen, P. C. van de Kerkhof, P. E. van Erp, R. Woestenenk, I. Joosten, and H. J. P. M. Koenen, “Foxp3 regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin,” The Journal of Investigative Dermatology, vol. 131, no. 9, pp. 1853–1860, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Komatsu, K. Okamoto, S. Sawa et al., “Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis,” Nature Medicine, vol. 20, no. 1, pp. 62–68, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Obermajer, F. C. Popp, Y. Soeder et al., “Conversion of Th17 into IL-17Aneg regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy,” The Journal of Immunology, vol. 193, no. 10, pp. 4988–4999, 2014. View at Publisher · View at Google Scholar
  46. E. Esplugues, S. Huber, N. Gagliani et al., “Control of TH17 cells occurs in the small intestine,” Nature, vol. 475, no. 7357, pp. 514–518, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. N. Gagliani, M. C. Vesely, A. Iseppon et al., “Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation,” Nature, 2015. View at Publisher · View at Google Scholar
  48. Y.-H. Wang, K. S. Voo, B. Liu et al., “A novel subset of CD4+ TH2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma,” Journal of Experimental Medicine, vol. 207, no. 11, pp. 2479–2491, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. L. Cosmi, L. Maggi, V. Santarlasci et al., “Identification of a novel subset of human circulating memory CD4+ T cells that produce both IL-17A and IL-4,” The Journal of Allergy & Clinical Immunology, vol. 125, no. 1, pp. 222.e4–230.e4, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Raymond, V. Q. Van, K. Wakahara, M. Rubio, and M. Sarfati, “Lung dendritic cells induce TH17 cells that produce TH2 cytokines, express GATA-3, and promote airway inflammation,” The Journal of Allergy and Clinical Immunology, vol. 128, no. 1, pp. 192.e6–201.e6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. N. Schmitt, Y. Liu, S. Bentebibel et al., “The cytokine TGF-β co-opts signaling via STAT3-STAT4 to promote the differentiation of human TFH cells,” Nature Immunology, vol. 15, no. 9, pp. 856–865, 2014. View at Publisher · View at Google Scholar
  52. K. Hirota, J.-E. Turner, M. Villa et al., “Plasticity of TH17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses,” Nature Immunology, vol. 14, no. 4, pp. 372–379, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. W. Zou and N. P. Restifo, “TH17 cells in tumour immunity and immunotherapy,” Nature Reviews Immunology, vol. 10, no. 4, pp. 248–256, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. I. Kryczek, M. Banerjee, P. Cheng et al., “Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments,” Blood, vol. 114, no. 6, pp. 1141–1149, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. X. Su, J. Ye, E. C. Hsueh, Y. Zhang, D. F. Hoft, and G. Peng, “Tumor microenvironments direct the recruitment and expansion of human Th17 cells,” Journal of Immunology, vol. 184, no. 3, pp. 1630–1641, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. D. Chen, R. Jiang, C. Mao et al., “Chemokine/chemokine receptor interactions contribute to the accumulation of Th17 cells in patients with esophageal squamous cell carcinoma,” Human Immunology, vol. 73, no. 11, pp. 1068–1072, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Li, H.-Y. Mo, G. Xiong et al., “Tumor microenvironment macrophage inhibitory factor directs the accumulation of interleukin-17-producing tumor-infiltrating lymphocytes and predicts favorable survival in nasopharyngeal carcinoma patients,” The Journal of Biological Chemistry, vol. 287, no. 42, pp. 35484–35495, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. Q. Yu, X. M. Lou, and Y. He, “Preferential recruitment of Th17 cells to cervical cancer via CCR6-CCL20 pathway,” PLoS ONE, vol. 10, no. 3, Article ID e0120855, 2015. View at Publisher · View at Google Scholar
  59. M. L. Ortiz, V. Kumar, A. Martner et al., “Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells,” Journal of Experimental Medicine, vol. 212, no. 3, pp. 351–367, 2015. View at Publisher · View at Google Scholar
  60. Y. Miyahara, K. Odunsi, W. Chen, G. Peng, J. Matsuzaki, and R.-F. Wang, “Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 40, pp. 15505–15510, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. X. Qian, L. Gu, H. Ning et al., “Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2,” The Journal of Immunology, vol. 190, no. 11, pp. 5894–5902, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. M. D. Sharma, D.-Y. Hou, Y. Liu et al., “Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes,” Blood, vol. 113, no. 24, pp. 6102–6111, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. K. S. Sfanos, T. C. Bruno, C. H. Maris et al., “Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing,” Clinical Cancer Research, vol. 14, no. 11, pp. 3254–3261, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. Z.-J. Ye, Q. Zhou, Y.-Y. Gu et al., “Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion,” The Journal of Immunology, vol. 185, no. 10, pp. 6348–6354, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. J.-P. Zhang, J. Yan, J. Xu et al., “Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients,” Journal of Hepatology, vol. 50, no. 5, pp. 980–989, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Tosolini, A. Kirilovsky, B. Mlecnik et al., “Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer,” Cancer Research, vol. 71, no. 4, pp. 1263–1271, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. S. He, M. Fei, Y. Wu et al., “Distribution and clinical significance of Th17 cells in the tumor microenvironment and peripheral blood of pancreatic cancer patients,” International Journal of Molecular Sciences, vol. 12, no. 11, pp. 7424–7437, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. E. Derhovanessian, V. Adams, K. Hähnel et al., “Pretreatment frequency of circulating IL-17+CD4+ T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients,” International Journal of Cancer, vol. 125, no. 6, pp. 1372–1379, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Punt, J. M. Langenhoff, H. Putter, G. J. Fleuren, A. Gorter, and E. S. Jordanova, “The correlations between IL-17 vs. Th17 cells and cancer patient survival: a systematic review,” OncoImmunology, vol. 4, no. 2, 2015. View at Publisher · View at Google Scholar
  70. C. M. Wilke, I. Kryczek, S. Wei et al., “Th17 cells in cancer: help or hindrance?” Carcinogenesis, vol. 32, no. 5, pp. 643–649, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. I. Kryczek, S. Wei, W. Szeliga, L. Vatan, and W. Zou, “Endogenous IL-17 contributes to reduced tumor growth and metastasis,” Blood, vol. 114, no. 2, pp. 357–359, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. L. Wang, T. Yi, M. Kortylewski, D. M. Pardoll, D. Zeng, and H. Yu, “IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway,” Journal of Experimental Medicine, vol. 206, no. 7, pp. 1457–1464, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. D. He, H. Li, N. Yusuf et al., “IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells,” Journal of Immunology, vol. 184, no. 5, pp. 2281–2288, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. F. Benchetrit, A. Ciree, V. Vives et al., “Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism,” Blood, vol. 99, no. 6, pp. 2114–2121, 2002. View at Publisher · View at Google Scholar · View at Scopus
  75. N. Hirahara, Y. Nio, S. Sasaki et al., “Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice,” Oncology, vol. 61, no. 1, pp. 79–89, 2001. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Numasaki, J.-I. Fukushi, M. Ono et al., “Interleukin-17 promotes angiogenesis and tumor growth,” Blood, vol. 101, no. 7, pp. 2620–2627, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Numasaki, M. Watanabe, T. Suzuki et al., “IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis,” Journal of Immunology, vol. 175, no. 9, pp. 6177–6189, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. T. Iida, M. Iwahashi, M. Katsuda et al., “Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer,” Oncology Reports, vol. 25, no. 5, pp. 1271–1277, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. J. Liu, Y. Duan, X. Cheng et al., “IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma,” Biochemical and Biophysical Research Communications, vol. 407, no. 2, pp. 348–354, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. X. Zhu, L. A. Mulcahy, R. A. A. Mohammed et al., “IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines,” Breast Cancer Research, vol. 10, no. 6, article R95, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. S. H. Chang, S. G. Mirabolfathinejad, H. Katta et al., “T helper 17 cells play a critical pathogenic role in lung cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 15, pp. 5664–5669, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. Z. Tong, X. O. Yang, H. Yan et al., “A protective role by interleukin-17F in colon tumorigenesis,” PLoS ONE, vol. 7, no. 4, Article ID e34959, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. K. Castermans, S. P. Tabruyn, R. Zeng et al., “Angiostatic activity of the antitumor cytokine interleukin-21,” Blood, vol. 112, no. 13, pp. 4940–4947, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. S. Punt, G. J. Fleuren, E. Kritikou et al., “Angels and demons: Th17 cells represent a beneficial response, while neutrophil IL-17 is associated with poor prognosis in squamous cervical cancer,” OncoImmunology, vol. 4, no. 1, Article ID e984539, 2015. View at Publisher · View at Google Scholar
  85. Z. Yang, B. Zhang, D. Li et al., “Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model,” PLoS ONE, vol. 5, no. 1, Article ID e8922, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. J. Ye, X. Su, E. C. Hsueh et al., “Human tumor-infiltrating Th17 cells have the capacity to differentiate into IFN-γ+ and FOXP3+ T cells with potent suppressive function,” European Journal of Immunology, vol. 41, no. 4, pp. 936–951, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. R. Du, H. Zhao, F. Yan, and H. Li, “IL-17+Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cells,” Journal of Leukocyte Biology, vol. 96, no. 1, pp. 39–48, 2014. View at Publisher · View at Google Scholar
  88. I. Kryczek, K. Wu, E. Zhao et al., “IL-17+ regulatory T Cells in the microenvironments of chronic inflammation and cancer,” Journal of Immunology, vol. 186, no. 7, pp. 4388–4395, 2011. View at Publisher · View at Google Scholar · View at Scopus
  89. C. Ma and X. Dong, “Colorectal cancer–derived Foxp3+IL-17+ T cells suppress tumour-specific CD8+ T cells,” Scandinavian Journal of Immunology, vol. 74, no. 1, pp. 47–51, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. S. Yang, B. Wang, C. Guan et al., “Foxp3+IL-17+ T cells promote development of cancer-initiating cells in colorectal cancer,” Journal of Leukocyte Biology, vol. 89, no. 1, pp. 85–91, 2011. View at Publisher · View at Google Scholar · View at Scopus
  91. C. Huang and Z.-X. Fu, “Localization of IL-17+Foxp3+ T cells in esophageal cancer,” Immunological Investigations, vol. 40, no. 4, pp. 400–412, 2011. View at Publisher · View at Google Scholar · View at Scopus
  92. B. Baban, P. R. Chandler, M. D. Sharma et al., “IDO activates regulatory T cells and blocks their conversion into Th17-like T cells,” The Journal of Immunology, vol. 183, no. 4, pp. 2475–2483, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. K. M. Dwyer, S. Deaglio, W. Gao, D. Friedman, T. B. Strom, and S. C. Robson, “CD39 and control of cellular immune responses,” Purinergic Signalling, vol. 3, no. 1-2, pp. 171–180, 2007. View at Publisher · View at Google Scholar · View at Scopus
  94. S. Deaglio, K. M. Dwyer, W. Gao et al., “Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression,” The Journal of Experimental Medicine, vol. 204, no. 6, pp. 1257–1265, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. F. Chalmin, G. Mignot, M. Bruchard et al., “Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression,” Immunity, vol. 36, no. 3, pp. 362–373, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. S. Nuñez, J. J. Saez, D. Fernandez et al., “T helper type 17 cells contribute to anti-tumour immunity and promote the recruitment of T helper type 1 cells to the tumour,” Immunology, vol. 139, no. 1, pp. 61–71, 2013. View at Publisher · View at Google Scholar · View at Scopus
  97. P. Muranski, A. Boni, P. A. Antony et al., “Tumor-specific Th17-polarized cells eradicate large established melanoma,” Blood, vol. 112, no. 2, pp. 362–373, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. P. Muranski, Z. A. Borman, S. P. Kerkar et al., “Th17 cells are long lived and retain a stem cell-like molecular signature,” Immunity, vol. 35, no. 6, pp. 972–985, 2011. View at Publisher · View at Google Scholar · View at Scopus
  99. L. Guery, J. Dubrot, C. Lippens et al., “Ag-presenting CpG-activated pDCs prime Th17 cells that induce tumor regression,” Cancer Research, vol. 74, no. 22, pp. 6430–6440, 2014. View at Publisher · View at Google Scholar
  100. A. Hamaï, P. Pignon, I. Raimbaud et al., “Human TH17 immune cells specific for the tumor antigen MAGE-A3 convert to IFN-γ-secreting cells as they differentiate into effector T cells in vivo,” Cancer Research, vol. 72, no. 5, pp. 1059–1063, 2012. View at Publisher · View at Google Scholar · View at Scopus
  101. J. Bekisz, S. Baron, C. Balinsky, A. Morrow, and K. C. Zoon, “Antiproliferative properties of type I and type II interferon,” Pharmaceuticals, vol. 3, no. 4, pp. 994–1015, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. H. Ikeda, L. J. Old, and R. D. Schreiber, “The roles of IFNγ in protection against tumor development and cancer immunoediting,” Cytokine & Growth Factor Reviews, vol. 13, no. 2, pp. 95–109, 2002. View at Publisher · View at Google Scholar · View at Scopus
  103. Y. Ma, G. V. Shurin, Z. Peiyuan, and M. R. Shurin, “Dendritic cells in the cancer microenvironment,” Journal of Cancer, vol. 4, no. 1, pp. 36–44, 2013. View at Publisher · View at Google Scholar · View at Scopus
  104. M. R. Shurin, G. V. Shurin, A. Lokshin et al., “Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies?” Cancer and Metastasis Reviews, vol. 25, no. 3, pp. 333–356, 2006. View at Publisher · View at Google Scholar · View at Scopus
  105. S. Tugues, S. H. Burkhard, I. Ohs et al., “New insights into IL-12-mediated tumor suppression,” Cell Death and Differentiation, vol. 22, no. 2, pp. 237–246, 2014. View at Publisher · View at Google Scholar
  106. S. F. Ngiow, M. W. L. Teng, and M. J. Smyth, “A balance of interleukin-12 and -23 in cancer,” Trends in Immunology, vol. 34, no. 11, pp. 548–555, 2013. View at Publisher · View at Google Scholar · View at Scopus
  107. D. Padua and J. Massagué, “Roles of TGFβ in metastasis,” Cell Research, vol. 19, no. 1, pp. 89–102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  108. Y. Zhao, E. Moon, C. Carpenito et al., “Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor,” Cancer Research, vol. 70, no. 22, pp. 9053–9061, 2010. View at Publisher · View at Google Scholar · View at Scopus
  109. M. Kalos, B. L. Levine, D. L. Porter et al., “T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia,” Science Translational Medicine, vol. 3, no. 95, Article ID 95ra73, 2011. View at Publisher · View at Google Scholar · View at Scopus
  110. M. H. Kershaw, J. A. Westwood, and P. K. Darcy, “Gene-engineered T cells for cancer therapy,” Nature Reviews Cancer, vol. 13, no. 8, pp. 525–541, 2013. View at Publisher · View at Google Scholar · View at Scopus
  111. S. Guedan, X. Chen, A. Madar et al., “ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells,” Blood, vol. 124, no. 7, pp. 1070–1080, 2014. View at Publisher · View at Google Scholar